Cisplatin-Based Neoadjuvant Chemotherapy for Elderly Patients with Muscle-Invasive Bladder Cancer: Is It Feasible?
暂无分享,去创建一个
A. Masson-Lecomte | S. Culine | E. Xylinas | H. Gauthier | C. Dumont | V. Fossey-Diaz | A. Arégui | Madeleine Lefèvre | Pierre Reignier | Quiterie Aussedat
[1] J. Lynch,et al. Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer , 2020, Investigative and clinical urology.
[2] S. Shariat,et al. Management of bladder cancer in older patients: Position paper of a SIOG Task Force. , 2020, Journal of geriatric oncology.
[3] S. Boorjian,et al. Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma. , 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[4] W. Mackillop,et al. Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing? , 2017, Urologic oncology.
[5] C. Ohyama,et al. Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study , 2017, Oncotarget.
[6] Jingsong Zhang,et al. Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience , 2017, Clinical genitourinary cancer.
[7] F. Saad,et al. Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study. , 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[8] E. Messing,et al. Bladder cancer in the elderly patient: challenges and solutions , 2015, Clinical interventions in aging.
[9] S. Crabb,et al. Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients. , 2015, European journal of cancer care.
[10] M. Parmar,et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] G. Sonpavde,et al. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. , 2011, The Lancet. Oncology.
[12] Yair Lotan,et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. , 2006, The Journal of urology.
[13] C. Vale. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .
[14] Nicholas J Vogelzang,et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.
[15] S. Groshen,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.